 High doses recombinant alpha-interferon gamma-interferon chronic hepatitis randomized trial Chronic hepatitis progressive liver disease satisfactory treatment efficacy recombinant alpha-interferon gamma-interferon treatment disease comparison control group patients groups patients MU body surface times mo mo mo patients gamma-interferon dose mo controls treatment mean serum ALT levels histological findings patients alpha-interferon changes patients gamma-interferon controls patients alpha-interferon complete responses mean ALT normal therapy treatment ALT pretreatment levels patients long-term response rate alpha-interferon therapy mo alpha-interferon effective disease activity portion patients chronic hepatitis High doses alpha-interferon benefit response rate relapse rate gamma-Interferon therapy ineffective